Table 1.
Hospital | Total SARS‐CoV‐2 RNA signal measured by | Measurement | Outbreak‐free periods vs. outbreaks [median (IQR)] | p‐value |
---|---|---|---|---|
1 | N1 | Copies/ml | 45.5 (11.1–145) vs. 719 (76.9–1141) | <0.001 |
Copies/copies PMMoV | 2.6 × 10−2 (6.5 × 10−3–6 × 10−2) vs. 2.3 × 10−1 (4.1 × 10−2–3.7 × 10−1) | <0.001 | ||
N200 | Copies/ml | 12.7 (3.1–20.3) vs. 347 (7.8–477) | 0.001 | |
Copies/copies PMMoV | 5.3 × 10−3 (1.6 × 10−3–1.3 × 10−2) vs. 8 × 10−2(7.7 × 10−3–1.8 × 10−1) | <0.001 | ||
2 | N1 | Copies/ml | 9.9 (5.1–73.9) vs. 167 (39–354) | <0.001 |
Copies/copies PMMoV | 4.8 × 10−3 (1.7 × 10−3–6.6 × 10−2) vs. 3.7 × 10−2 (1.3 × 10−2–3 × 10−1) | 0.005 | ||
N200 | Copies/ml | 5.2 (0.7–18.5) vs. 36.6 (13.3–220) | <0.001 | |
Copies/copies PMMoV | 3 × 10−3(2.6 × 10−4–1.4 × 10−2) vs. 1.5 × 10−2 (3.3 × 10−3–8.4 × 10−2) | 0.007 | ||
3A | N1 | Copies/ml | 20.5 (3.9–47.1) vs. 211 (118–303) | 0.033 |
Copies/copies PMMoV | 1.8 × 10−2 (4.9 × 10−3–7 × 10−2) vs. 1.2 × 10−1 (5.2 × 10−3–2.4 × 10−1) | 0.723 | ||
N200 | Copies/ml | 12.6 (2.7–35.8) vs. 204 (47.8–361) | 0.052 | |
Copies/copies PMMoV | 9.5 × 10−3 (2.1 × 10−3–3.5 × 10−2) vs. 1.5 × 10−1(2.1 × 10−3–2.9 × 10−1) | 0.723 | ||
3B | N1 | Copies/ml | 10.3 (1.1–22.7) vs. 105 (4.8–447) | 0.003 |
Copies/copies PMMoV | 4.5 × 10−3 (3.1 × 10−4–8.1 × 10−3) vs 6.1 × 10−2 (2.4 × 10−3–1.3 × 10−1) | 0.008 | ||
N200 | Copies/ml | 1.3 (0–7.4) vs. 34.7 (1.1–158) | 0.006 | |
Copies/copies PMMoV | 4.2 × 10− 4 (0–3.7 × 10−3) vs. 2.1 × 10−2 (1.9 × 10−4–5.4 × 10−2) | 0.014 | ||
3C | N1 | Copies/ml | 3.3 (0−13.5) vs. 77 (15.8−269) | 0.003 |
Copies/copies PMMoV | 2.5 × 10−3 (0–1.1 × 10−2) vs. 5.2 × 10−2 (3.6 × 10−3–5.2 × 10−1) | 0.003 | ||
N200 | Copies/ml | 0.6 (0–5.3) vs. 91.6 (11.3–260) | <0.001 | |
Copies/copies PMMoV | 2.3 × 10−4 (0–3.9 × 10−3) vs. 2.9 × 10−2 (2.2 × 10−3–5.2 × 10−1) | <0.001 |
Abbreviation: IQR, interquartile range.